Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

NCT02873390 is registered in ClinicalTrials.gov with Ningbo Cancer Hospital as lead sponsor.

NCT NCT02873390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02873390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor
Lead sponsor
Ningbo Cancer Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
July 31, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancies, car-t cells, pd-1 antibody